Home > Boards > US OTC > Medical - Healthcare > InVivo Therapeutics Holdings Corp (NVIV)

An email from WIRB who is supposed to

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
kingofthepuppies Member Profile
 
Followed By 0
Posts 4
Boards Moderated 0
Alias Born 03/14/19
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/27/2019 7:42:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/27/2019 7:40:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/27/2019 7:39:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2019 4:31:36 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2019 8:02:28 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2019 4:30:59 PM
InVivo Therapeutics Announces Publication of CONTEMPO Registry Study Data in Peer-Reviewed Journal Spinal Cord Business Wire - 7/16/2019 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/12/2019 8:12:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/12/2019 8:06:17 AM
InVivo Therapeutics Announces Postponement of Annual Meeting Business Wire - 7/12/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/5/2019 8:01:02 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/1/2019 6:00:53 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/21/2019 4:08:00 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 6/21/2019 8:02:13 AM
InVivo Therapeutics gibt Vertagung der Hauptversammlung bekannt Business Wire - 6/14/2019 1:21:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2019 8:06:21 AM
InVivo Therapeutics Announces Adjournment of Annual Meeting Business Wire - 6/14/2019 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/14/2019 7:51:21 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/5/2019 8:10:45 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/5/2019 8:07:49 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/30/2019 6:01:28 AM
InVivo Therapeutics Announces Enrollment of First Two Patients into the INSPIRE 2.0 Study for the Treatment of Acute Spinal C... Business Wire - 5/29/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/22/2019 5:56:59 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 5/17/2019 4:37:53 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 8:03:06 AM
kingofthepuppies   Thursday, 03/14/19 05:24:32 PM
Re: None
Post # of 6120 
An email from WIRB who is supposed to be involved in qualifying medical centers for recruitment of INSPIRE2 clinical trial says they have no file on the study.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist